American National Insurance’s Thermo Fisher Scientific TMO Stock Holding History

American National Insurance’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$5.38M	Sell	9,100 -2,490	-21%	-$1.43M	1.45%	9
2021 Q4	$7.73M	Sell	11,590 -49,785	-81%	-$31.1M	1.71%	7
2021 Q3	$35.1M	Sell	61,375 -75	-0.1%	-$41.2K	1.32%	9
2021 Q2	$31M	Sell	61,450 -135	-0.2%	-$63.7K	1.16%	13
2021 Q1	$28.1M	Sell	61,585 -65	-0.1%	-$31K	1.15%	12
2020 Q4	$28.7M	Hold	61,650	–	–	1.23%	13
2020 Q3	$27.2M	Hold	61,650	–	–	1.31%	11
2020 Q2	$22.3M	Hold	61,650	–	–	1.16%	13
2020 Q1	$17.5M	Hold	61,650	–	–	1.13%	13
2019 Q4	$20M	Sell	61,650 -4,000	-6%	-$1.21M	1.04%	14
2019 Q3	$19.1M	Hold	65,650	–	–	1.02%	16
2019 Q2	$19.3M	Hold	65,650	–	–	1.03%	19
2019 Q1	$18M	Hold	65,650	–	–	0.94%	24
2018 Q4	$14.7M	Hold	65,650	–	–	0.86%	29
2018 Q3	$16M	Hold	65,650	–	–	0.79%	29
2018 Q2	$13.6M	Hold	65,650	–	–	0.67%	41
2018 Q1	$13.6M	Hold	65,650	–	–	0.69%	41
2017 Q4	$12.5M	Hold	65,650	–	–	0.63%	51
2017 Q3	$12.4M	Hold	65,650	–	–	0.65%	45
2017 Q2	$11.5M	Hold	65,650	–	–	0.63%	52
2017 Q1	$10.1M	Hold	65,650	–	–	0.56%	56
2016 Q4	$9.26M	Hold	65,650	–	–	0.54%	56
2016 Q3	$10.4M	Hold	65,650	–	–	0.61%	46
2016 Q2	$9.7M	Hold	65,650	–	–	0.57%	51
2016 Q1	$9.29M	Sell	65,650 -300	-0.5%	-$40.2K	0.55%	52
2015 Q4	$9.36M	Hold	65,950	–	–	0.55%	53
2015 Q3	$8.06M	Hold	65,950	–	–	0.51%	63
2015 Q2	$8.56M	Hold	65,950	–	–	0.51%	61
2015 Q1	$8.86M	Hold	65,950	–	–	0.52%	58
2014 Q4	$8.26M	Hold	65,950	–	–	0.49%	61
2014 Q3	$8.03M	Hold	65,950	–	–	0.49%	64
2014 Q2	$7.78M	Hold	65,950	–	–	0.47%	68
2014 Q1	$7.93M	Hold	65,950	–	–	0.51%	59
2013 Q4	$7.34M	Hold	65,950	–	–	0.47%	70
2013 Q3	$6.08M	Hold	65,950	–	–	0.43%	73
2013 Q2	$5.58M	Buy	+65,950	New	+$5.49M	0.42%	79

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American National Insurance's TMO Position: Q1 2022 in Review

American National Insurance reduced its Thermo Fisher Scientific (TMO) stake by 21% in Q1 2022, selling an estimated $1.43M and leaving 9,100 shares worth $5.38M. The position accounts for 1.45% of the portfolio, ranked #9.

American National Insurance first reported a position in TMO in Q2 2013 and has held it in 36 quarters since. The position peaked at $35.1M in Q3 2021. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

American National Insurance held 9,100 shares of Thermo Fisher Scientific worth $5.38M as of Q1 2022.
American National Insurance sold 2,490 Thermo Fisher Scientific shares in Q1 2022, an estimated $1.43M.
Thermo Fisher Scientific made up 1.45% of American National Insurance's portfolio in Q1 2022, its #9 holding.
American National Insurance first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 36 quarters since.
American National Insurance's Thermo Fisher Scientific position peaked at $35.1M in Q3 2021.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.